Get the latest tech news
New studies offer insight into Lyme disease’s treatment, lingering symptoms
In two new studies led by bacteriologist Brandon L. Jutras, Northwestern scientists have identified an antibiotic that cures Lyme disease at a fraction of the dosage of the current “gold standard” treatment and discovered what may cause a treated infection to mimic chronic illness in patients.
In two new studies led by bacteriologist Brandon L. Jutras, Northwestern scientists have identified an antibiotic that cures Lyme disease at a fraction of the dosage of the current “gold standard” treatment and discovered what may cause a treated infection to mimic chronic illness in patients. Northwestern scientists believe they now know what causes the treated infection to mimic chronic illness: The body may be responding to remnants of the Borrelia cell wall which breaks down during treatment yet lingers in the liver. Lyme prevention also remains a challenge — no approved human vaccine exists — and Jutras hopes his research moving forward will help with developing proactive strategies to diagnose and treat it.
Or read this on Hacker News